A Method for Efficiently and Reproducibly Generating Expandable Liver Organoids from Human Induced Pluripotent Stem Cells for Disease Modeling
Liver diseases affect millions of people worldwide and pose a significant burden on healthcare systems. To better understand these diseases and develop effective treatments, researchers have turned to organoids – miniature, three-dimensional organ-like structures grown in the lab. These organoids mimic the structure and function of real organs, providing a valuable tool for disease modeling and drug discovery.
In recent years, human induced pluripotent stem cells (hiPSCs) have emerged as a promising source for generating organoids. These cells can be derived from adult cells, such as skin cells, and reprogrammed to an embryonic-like state. They have the ability to differentiate into any cell type in the body, including liver cells or hepatocytes.
However, generating liver organoids from hiPSCs has been challenging due to the complexity of the liver’s cellular composition and function. Existing methods often result in low efficiency and variability, making it difficult to obtain reproducible results. To address these limitations, a team of scientists has developed a novel method for efficiently and reproducibly generating expandable liver organoids from hiPSCs.
The key innovation of this method lies in the use of a specific combination of growth factors and culture conditions that promote the differentiation of hiPSCs into hepatocytes. The researchers identified a cocktail of growth factors that mimic the signaling pathways involved in liver development during embryogenesis. By carefully controlling the timing and concentration of these factors, they were able to guide the hiPSCs towards becoming hepatocytes.
To further enhance the efficiency and reproducibility of the process, the researchers also optimized the culture conditions for the growing liver organoids. They developed a specialized culture medium that provides the necessary nutrients and support for the organoids to grow and expand. This medium also contains factors that promote the maturation of the hepatocytes, making the organoids more physiologically relevant.
The researchers validated the effectiveness of their method by generating liver organoids from multiple hiPSC lines and comparing them to real human liver tissue. They found that the organoids closely resembled the structure and function of the liver, exhibiting key features such as bile production and drug metabolism. Importantly, the method consistently produced high-quality organoids with minimal variability between different batches.
The expandability of these liver organoids is another significant advantage of this method. The researchers demonstrated that the organoids could be expanded over multiple passages without losing their hepatocyte characteristics. This expandability allows for large-scale production of liver organoids, making them suitable for high-throughput screening of drugs and personalized medicine applications.
In conclusion, the development of an efficient and reproducible method for generating expandable liver organoids from hiPSCs represents a significant advancement in disease modeling and drug discovery. These organoids provide a valuable tool for studying liver diseases, understanding their underlying mechanisms, and testing potential therapies. With further refinement and optimization, this method holds great promise for advancing our knowledge of liver biology and improving patient care in the future.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: Plato Data Intelligence.
- Source Link: https://platohealth.ai/efficient-and-reproducible-generation-of-human-induced-pluripotent-stem-cell-derived-expandable-liver-organoids-for-disease-modeling-scientific-reports/